GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: PF-06823859 | PF06823859
Compound class:
Antibody
Comment: Dazukibart (PF-06823859) is a humanized monoclonal antibody that selectively neutralises interferon-beta (IFN-β) and blocks signalling via interferon receptors (IFNAR) [1]. Peptide sequences for the heavy and light chains of dazukibart are claimed as components of antibody CTI-AF1 in Pfizer's patent US10829553 [2].
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 12518 | dazukibart |
Synonyms ![]() |
| PF-06823859 | PF06823859 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 1395 |
| Other databases | |
| Search PubMed clinical trials | dazukibart |
| Search PubMed titles | dazukibart |
| Search PubMed titles/abstracts | dazukibart |